Background. Clinical practice, policy and research, and the ethical bases upon which they are founded, should be systematically and transparently informed by both patient and professional values. Methods. A discrete choice experiment was utilized to understand and quantify the preferences of 351 Canadian patients and healthcare providers in relation to ethically challenging aspects of the management of chronic kidney disease (CKD): procurement and allocation of organs for transplantation, end-of-life care discussions and decision making and the identities of those providing primary care. Results. Patients and health professionals had clear preferences for detailed prognostic information, early advance care planning, shared end-of-life decision making, coordinated models of care that enhance interaction and communication between primary and tertiary care and a more utilitarian approach of best match over first come, first served for allocating deceased donor kidneys. These data also suggest that the innovative strategies of non-directed anonymous donation and paired kidney exchange that are slowly being implemented internationally will be acceptable to both patients and healthcare providers. Conclusions. Current models of CKD care do not consistently reflect the preferences or priorities of either health professionals or patients.
Introduction
The rapidly increasing numbers of patients, escalating healthcare costs and the physical, psychosocial and financial consequences of living with chronic kidney disease (CKD) create ethical challenges in providing care. Questions such as who should provide care and how that care should be provided are becoming increasingly relevant.
Access to, and provision of, quality end-of-life care remain suboptimal, and public perceptions of priority setting, especially in the context of highly political issues such as organ procurement and allocation for transplantation, are central issues in the development of effective CKD programmes. Yet these programmatic aspects of care have not been sufficiently studied.
Contemporary policy focuses on evidence-based medicine [1] , the practice of which requires integrating individual clinical expertise with the best available clinical evidence from systematic research. Clinical expertise includes a 'more thoughtful identification and compassionate use of individual patients' rights and preferences [2] .' The individual, therefore, is the often forgotten tenant of evidence-based medicine. Novel methodologies are emerging in healthcare to systematically study patient preferences to allow clinical programmes to integrate best evidence while being responsive to individuals' needs and priorities [3] .
The aim of this study was to understand the preferences of patients, primary caregivers and health professionals in relation to ethically challenging aspects of CKD management, thus expanding current assumptions necessary for developing effective and appropriate healthcare policy in ways which reflect both patient and professional values more equitably. This study specifically addressed the procurement and allocation of organs for transplantation, endof-life care and care provider issues.
Materials and methods

Study participants
Three participant groups were recruited. (i) A stratified (age <65; ≥65, gender), random sample of CKD patients in the Northern Alberta Renal Program (a Canadian, university-based programme). This consisted of dialysis patients, transplant recipients and patients enrolled in a pre-dialysis clinic undergoing education for renal replacement options. (ii) The principal caregiver to each patient (as identified by the patient). (iii) Random samples of health professionals involved in the care of CKD patients in northern Alberta. Family physicians were identified using the membership lists of the Alberta College of Family Physicians. Renal nurses and nephrologists were identified from Northern Alberta Renal Program staff lists. Patients and family caregivers had to be ≥18years of age, give informed consent, be able to complete the questionnaire in English or have a family member available to help translate and judged on examination of the medical chart to have no significant psychological or psychiatric problems.
Eligible subjects were contacted by a letter inviting them to participate accompanied by a study information sheet, a consent form, the study survey and a prepaid return envelope. Consenting patients identified their principal caregiver and a similar package was mailed to these individuals. Non-responders were contacted by telephone once only.
The discrete choice experiment survey
Discrete choice experiments (DCE) are an established methodology in health economics to examine preferences for healthcare treatments or programmes. They have been used in nephrology to study preference for prioritization of patients for renal transplantation [4] [5] [6] . Our application is novel in its focus on the programmatic aspects of provision of CKD care. The method assumes that CKD programmes can be described in terms of their characteristics or attributes, and preferences between programmes depend upon those attributes. The relative importance of these preferences can be assessed from choices between hypothetical programmes created with different combinations of the attributes [4] .
In this DCE, respondents were asked to choose between hypothetical CKD programmes that differed according to aspects of CKD management that have been highlighted in the literature as substantial ethical challenges to the nephrology community: end-of-life care, transplantation and care provider issues. Table 1 describes potential alternatives for each attribute. The main stages to carrying out a DCE are described below.
Creating choice scenarios. combinations of attribute levels to describe sets of hypothetical CKD programmes were generated using experimental design techniques. An orthogonal main effects design was constructed that incorporated five two-factor interactions allowing the main effects of each attribute to be estimated independently of one another [7] , resulting in 48 choice sets. (It was hypothesized, a priori, that preferences for some of the attributes might depend upon other attributes of the program. However, none of these interactions were significant and thus these data are not presented.) 1 An example choice is shown in Figure 1 .
The survey. the 48 choice sets were blocked into four versions of a 12-question, self-completion, postal survey. A detailed description of the attributes and their corresponding levels along with instructions on how to fill out the questionnaire were included. Respondents had to make tradeoffs, because choosing scenarios with a more preferred level in one attribute may result in a less preferred level in another. Assessing respondents' trade-offs allows for an overall benefit score to be calculated for the various levels of each attribute. The survey also requested pertinent demographic information.
Analysis. DCE is based on random utility theory. It assumes that people choose the option they most value. This value is represented by a utility function which is dependent upon both the attributes and levels in a choice set, as well as a random error component. A fixed effects multinomial logit regression [8] was used to analyse the data which account for the fact that there are multiple choice observations per individual. Stata 8.2 was used to perform all analyses (StataCorp LP, College Station, TX). The sample size needs for a DCE are determined by the planned subgroup analyses with a minimum of 60 respondents per subgroup of interest. The sign of the regression coefficients indicates the direction of preferences for that level of the attribute, relative to the current practice in northern Alberta. (That is, the variable is equal to one if that level is present and zero otherwise and is used to represent which level of the attribute is in a given choice set. For example, for the attribute 'when should advanced care planning be started' there are two levels (early and late in illness). We construct a dummy variable which is 1 if the level is 'early in illness' and zero otherwise. One of the variables must be excluded. We omitted the level which most closely resembles current clinical practice in Alberta.)
Results
Of 465 mailed surveys, 351 (75%) were completed and returned. Non-responders did not differ from responders with respect to age, gender, geographic location or dialysis modality. Three respondents did not indicate their participant group and were excluded from the analysis. We were unable to recruit adequate numbers of primary caregivers for a subgroup analysis due to lack of available family members and patient reluctance to burden caregivers with the survey. For the analysis, caregivers were added to the patient participant group. When caregivers were excluded from the analysis, results did not change. Participants are described in • First come, first served • Best match 3. How should live kidneys for transplantation be obtained?
• Family member or emotionally related • Paired kidney exchange • Anonymous donor • Buy a kidney 4. When should end-of-life care discussions (advance care planning) be started?
• Early in illness (e.g. onset of dialysis or prior to initiating dialysis) • Late in illness (e.g. when health state is obviously failing and death may be imminent) 5. How much information on prognosis and end-of-life care issues should be routinely provided?
• Limited information • Detailed information 6. How should decisions to stop dialysis be made?
• Personal decision • Shared decision with the medical team that combines personal preferences and medical facts professionals were married, and as a result of the high representation of nursing, were women. Survey completion rate was 98%. Coefficient estimates from the multinomial regression are shown in Table 3 . Almost all coefficients were significant at the 95% level, indicating that all attributes were perceived important and were taken into consideration when making choices between hypothetical CKD programmes. The model had good fit, predicting 74% of responses correctly. A positive coefficient means that the level of the attribute is more preferred than the level most closely representing current practice: a negative coefficient represents a less preferred level. For example, the coefficient for the early advance care planning variable is positive which indicates that early advance care planning is preferred to late advance care planning (which is the reference category as this most closely represents current practice in Alberta). This indicates that respondents are more likely to choose a CKD programme that has early advance care planning, all other characteristics being the same. The magnitude of the coefficient indicates the order of preference for the levels of that attribute. For example, for the attribute 'How should live kidneys be obtained', the preferred level is the reference category (family member/close friend) as the coefficients on the other levels are all negative. The smallest coefficient is for buying a kidney, indicating that it is the least preferred option for obtaining live kidneys for transplantation.
Patients and health professionals preferred early advanced care planning, detailed information about prognosis and end-of-life issues, shared decision making for the discontinuation of dialysis taking into account medical factors as well as personal preferences and the allocation of deceased donor kidneys based on best match. Patients and healthcare providers were in agreement that the preferred source for live donation was a family member or close friend (both related and unrelated). For healthcare providers this was followed by an anonymous donor and then paired kidney exchange. Patients varied slightly in that paired kidney exchange was preferred over an anonymous donation, although for both groups, there was very little difference between these two latter options, and all three options were considered acceptable. Buying a kidney was deemed unacceptable by all respondents. Both patients and healthcare providers were in agreement that the least preferred option for provision of primary care was a family physician alone. Healthcare providers had a clear order of preference for a family practitioner in conjunction with kidney specialists, followed by an advanced nurse practitioner with kidney specialists and finally kidney specialists alone. Patients preferred that care be provided by any one of the above approaches over the family physician alone.
Although preferences for the levels within each attribute were similar between patients and healthcare providers, there were differences in prioritizing various attributes with the most striking differences between who provides comprehensive primary care and advanced care planning (Table 4) . Health professionals were more willing to make trade-offs with other attributes to ensure early advanced care planning than patients, while patients were more willing to make trade-offs to ensure they selected the CKD programme that incorporated their preferences for who provided their medical care.
Discussion
Chronic disease is a leading cause of mortality, morbidity and healthcare utilization. Research on innovative methods to treat chronic illness is high on the agenda of policy makers and organizations funding health research. Challenges in caring for these patients are born from the long duration and complex nature of chronic disease, including the dynamic interaction between individuals and their social, spiritual and physical environments and conflicts between professional and patient priorities. This study illustrates the use of DCE to better understand and quantify the preferences and priorities of patients and healthcare providers in Preferences for CKD programmes 2337
northern Alberta for several ethically challenging aspects of CKD management. End-of-life care discussions and decision making, the identities of those providing primary care, live organ procurement and the allocation of deceased donor kidneys for transplantation were all considered important elements of a CKD programme by participants and were taken into consideration when selecting hypothetical CKD programmes.
Provision of comprehensive day-to-day care
Who provides the comprehensive day-to-day care for CKD patients is a challenge for many CKD programmes. Collaborative management between primary care providers and nephrologists was seen as the preferred model of care by both patients and healthcare providers in this study. CKD patients require frequent, ongoing interaction, often over several years, with their nephrology team. Many patients lose contact with their primary care physician, becoming increasingly dependent upon the nephrologist for comprehensive care. With the growing numbers of CKD patients and the large geographic regions that many CKD programmes service, nephrologists are unable to provide equitable, high quality service consistently to all patients. Finding alternate models of care that are appropriate for patients and healthcare providers is a priority.
Due to the complex nature of chronic disease management, primary care physicians may not be comfortable with providing the necessary care for CKD patients [9] . The initiation of care by nephrologists for stage 3 CKD is beneficial with respect to delaying the onset of end-stage renal disease and improving survival [10] , lending support for early referral to nephrology [11] . A recent Spanish study showed that CKD patients attended to in primary care centres had poorer control of their heart disease risk factors than those with normal renal function [12] .
However, nephrologists are not always ideally suited to address the myriad of primary care concerns of CKD patients. In addition, limitations in the capacity of currently practicing nephrologists may prevent widespread early referral. CKD care requires the participation of highly active multidisciplinary teams, including dieticians, nurses, social workers and family physicians. Much of the care needed for effective CKD management can be performed in the community by these individuals. Primary care physicians in Mexico with adequate training reproduced very closely the actions of nephrologists [13] . Chronic disease management programmes within North America and the UK have been shown to be effective in improving patient outcomes and reducing resource utilization [14, 15] . Although the contribution of primary care to the management of CKD has not been adequately researched, our data suggest that these patients and healthcare providers would have a positive response toward it.
End-of-life care
The annual death rate for dialysis patients in North America and the UK is ∼22% with almost one in four deaths preceded by a decision to withdraw dialysis [16] . Unfortunately, the majority of patients are not involved in these decisions as they lack decision-making capacity at the time the decision to withdraw dialysis is made as end-of-life care discussions regarding appropriate withdrawal of dialysis have not been systematically incorporated into CKD programmes [17] . The reasons are complex and beyond the scope of this study, but often involve a reluctance to initiate early discussions about prognosis and a lack of understanding about how decisions to withdraw dialysis should be made [18, 19] . In this study, patients and providers were in agreement that the provision of detailed information about prognosis and end-of-life issues to patients is preferred to limited information; early advanced care planning (i.e. at the initiation of renal replacement therapy when the patient is still well) is preferred to late (when death is more clearly imminent); and that shared decision making for withdrawing dialysis should take into account medical factors as well as patients' personal preferences. These preferences do not reflect current clinical practice in North America and the UK but are consistent with what little data are available on patient preferences in the literature. In one Canadian study, the majority of patients starting dialysis (97%) wanted to be given life-expectancy information, and for the physician to do so without having to be prompted [20] . An earlier study also highlighted that dialysis patients perceive they are inadequately involved in their medical decision making and want high levels of information [21] . It should be noted, however, that there is little longitudinal research to elucidate whether preferences and priorities change as patients become less well.
Transplantation
The number of patients waiting for a kidney transplant in the UK has increased by 36% within the last decade. The increasing gap between supply and demand for organs has led to intense politicization of kidney procurement and allocation policies, and internationally numerous innovative procurement and allocation systems have been proposed. These policies need to balance the competing philosophies of equity (a fair opportunity for everyone in need) and utility (optimal gain from each organ) and remain consistent with patients' and health professionals' values and beliefs. However, data on the preferences and values of professionals, patients and the general public as they relate to organ procurement and allocation for kidney transplantation remain limited.
Living donor transplantation accounts for approximately half of all kidney transplants performed in the USA and several European countries [22] and compared to deceased donor transplantation is less expensive [23] , yields better patient and graft survival rates, can pre-empt the use of dialysis, limits time on waiting lists and allows the deceased donor kidneys to be used for those without a living donor [22, 24, 25] . Data from Spain and Italy suggest that healthcare providers, patients and the public are generally in favour of related living organ donation [26, 27] . For healthcare providers, rates of acceptance decrease from 88-90% to 10-23% if the living donor is nonrelated [28] [29] [30] . Innovative strategies to increase live donation such as non-directed anonymous donation [31] and paired kidney exchange are required as the number of suitable deceased kidney donors will not meet the increasing need for kidney donors, no matter how efficient the retrieval process [32, 33] . A living donor paired exchange allows two separate donors who are each unable to donate to their intended recipients due to blood group or antibody incompatibility to be matched with the other's respective recipient so that each recipient can receive a compatible living kidney transplant. In a recent study, 22% of 180 living donors were excluded because of blood group incompatibility and another 32% due to antibody incompatibility [34] . Kidney paired donation has had great success in South Korea and the Netherlands and has been started in some centres in the USA and Canada [35] . Our data suggest that living donation (related or unrelated), and that the more innovative strategies of non-directed anonymous donation and paired kidney exchange that are being proposed and slowly implemented internationally, will be acceptable to both patients and healthcare providers.
The organ shortage has lead to many transplant centres across North America and Europe to accept kidneys from old, suboptimal deceased donors. The proportion of donors fulfilling the United Network for Organ Sharing (UNOS) criteria for these extended criteria donors has increased dramatically from 2.9 to 26.3% in the last decade [36] . The principle of equity as illustrated by the first-come, first-served queue demands that each person who would benefit from kidney transplant should have comparable opportunity to receive one. Following this principle, extended criteria donors may be allocated to patients that have a life expectancy beyond that of graft survival. Conversely, 'optimal' kidneys may be allocated to a patient with an expected survival less than that of graft survival, therefore reducing the potential of that graft. With improvements in immunosuppressive therapy, patient death with a functioning graft has become a leading cause of graft loss after the first transplant year [36] . The utilitarian approach to allocation aims to decrease this wasted potential graft life by allowing organs which are expected to function for many years to be transplanted into patients who are expected to live for many years. Similarly, patients with fewer expected years of life would be deemed appropriate candidates for extended criteria kidneys with fewer years of expected graft life. Adopting a utilitarian approach, however, may result in longer waiting lists for certain patients and limits transplant opportunities for older, sicker patients, and there are concerns that it may decrease donation rates due to further mistrust in a system that is already perceived as complex and unjust [37] .
Maximizing utility is a high priority for Eurotransplant, the organ sharing organization for seven European countries (Australia, Croatia, Germany, Luxemburg, Slovenia, The Netherlands and Belgium). In the UK, the allocation system was designed to maximize the number of recipients that received a well-matched graft. However, in 2006 a new allocation system was implemented (www.uktransplant.org.uk) due to adverse effects on equity. In North America, an egalitarian approach, using wait list time, is strongly emphasized [38] . However, there is growing interest to increase the life-prolonging potential of deceased donor kidneys, and a number of utility-based allocation systems have been proposed [39] . These include various adaptations of agematching such as with the Eurotransplant Senior Program [37] .
In this study, respondents preferred a more utilitarian to egalitarian approach for allocating deceased donor kidneys, to allow maximum flexibility to accommodate advances in renal transplant such as the use of marginal donors. These data suggest that patients and healthcare professionals would support the addition of utility measures to the firstcome, first-served queue of many current allocation systems. Clearly, the ongoing debate surrounding these issues needs to reflect not only the clinical picture of renal transplantation but our evolving understanding of the values and preferences of both patients and healthcare providers [39] .
Prioritization of various aspects of CKD programmes
A striking finding was that all participants had a strong aversion to buying a kidney which overrode preferences for all other attributes. Kidney vending, once considered taboo in many countries, is increasingly being debated [40, 41] with the current prohibition of organ sales being derided and described by some as 'outdated' and 'divorced from the real world' [42] . Specific proposals for the implementation of kidney sales have recently been made [41] . Although a debate of the pros and cons of kidney vending is beyond the scope of this paper, our data clearly demonstrate that the very people that would have the most to gain were unanimously opposed to the selling of kidneys. Irrespective of whether patients were considered medically eligible for a transplant, participants' opposition was more important than all other aspects of the CKD programme. This suggests that the implementation of a kidney vending policy would not have a positive impact on CKD programmes as perceived by these healthcare providers or patients.
The issue of who provides comprehensive care was the second most important aspect of care for patients when selecting a CKD programme. This should send a clear message to nephrology programmes that the model of care should incorporate clear and effective integration and communication of care between the nephrology team and the primary care physician. How kidneys are allocated from deceased donors was the third most important attribute for patients when selecting a CKD programme. This was once again regardless of whether they were considered medically eligible for a transplant or not. We can speculate that patients and healthcare providers value programmes and policies that reflect their values of social justice.
An editorial in the British Medical Journal highlighted the increasing pressure to take account of providers' and patients' preferences, yet to date systematic consideration of such preferences has been limited [5] . The DCE methodology is increasingly being applied to health and healthcare to elicit preferences with a view to informing policy [43, 44] and appears to have encouraging results concerning reliability and validity when applied in a health context [45] . Respondents are not required explicitly to quantify the strength of their preference for selected scenarios, unlike other preference methods such as willingness to pay. However, the choice task is still a considerable cognitive challenge [43] , especially for CKD patients who are at high risk for cognitive dysfunction and who may be functioning under con-ditions of considerable personal stress. Regardless, these patients appeared to engage appropriately in the process.
These findings represent the first known example of empirical evidence for patient valuations of ethical issues in CKD programmes in relation to those held by key groups of professionals using contemporary research methods. This knowledge is important as decisions about clinical practice and policy should be systematically and transparently informed by patient and professional values. Healthcare policy that incorporates detailed prognostic information, early advance care planning, shared end-of-life decision making, coordinated models of care that enhance interaction and communication between primary and tertiary care and a more utilitarian approach of best match over first come, first served for allocating deceased donor kidneys is necessary for providing CKD care in ways which reflect both patient and professional values more equitably. The prioritization of concerns among attributes also helps to guide funding decisions. Current models of CKD care do not consistently reflect the preferences or priorities of either healthcare professionals or patients.
